Literature DB >> 266334

Cell aggregates in malignant mesothelioma.

D Whitaker.   

Abstract

The finding in cell block sections of a central core of collagen within tumour aggregates in 4 out of 12 cases of effusions due to malignant mesothelioma is statistically significant (P greater than .01) when compared with its incidence in 2 of 80 cases of effusion due to metastatic carcinoma. It is suggested that this observation may be of diagnostic value in the cytologic evaluation of effusions when malignant mesothelioma is suspected.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266334

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  6 in total

Review 1.  Diffuse malignant mesothelioma: a review.

Authors:  W N Rom; J E Lockey
Journal:  West J Med       Date:  1982-12

2.  Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids.

Authors:  Dario Barbone; Tsung-Ming Yang; Jeffrey R Morgan; Giovanni Gaudino; V Courtney Broaddus
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

3.  Secreting peritoneal mesothelioma. Report of a case with cytological, ultrastructural, morphometric and histological studies.

Authors:  M E Boon; H S Posthuma; D J Ruiter; J G von Andel
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

4.  Isolation and properties of cell lines from the metastasising rat mammary tumour SMT-2A.

Authors:  P S Rudland; D J Dunnington; U Kim; B A Gusterson; M J O'Hare; P Monaghan
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

Review 5.  Architectural aspects of cell-blocks as small biopsies.

Authors:  Swati Satturwar; Liron Pantanowitz
Journal:  Cytojournal       Date:  2021-03-04       Impact factor: 2.091

Review 6.  Approach to Diagnostic Cytopathology of Serous Effusions.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.